The MAVEN® Real Time Glucose Control Platform from Repligen will be used to perform real-time monitoring of glucose and lactate in the range of scale-X™ bioreactors for adherent cell culture processes.
Read article "Repligen Corporation & Univercells Technologies Partner to Enable Real-Time Monitoring of Viral Vector and Vaccine Biomanufacturing"